These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25174697)

  • 1. Memantine in the treatment and prophylaxis of bipolar type II mood disorder and co-morbid eating disorder: a case report.
    De Chiara L; Serra G; Koukopoulos AE; Koukopoulos A; Serra G
    Riv Psichiatr; 2014; 49(4):192-4. PubMed ID: 25174697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report.
    Serra G; DE Chiara L; Koukopoulos AE; Koukopoulos A; Serra G; Kahn DA
    J Psychiatr Pract; 2014 May; 20(3):232-6. PubMed ID: 24847998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder.
    Koukopoulos A; Reginaldi D; Serra G; Koukopoulos A; Sani G; Serra G
    Bipolar Disord; 2010 May; 12(3):348-9. PubMed ID: 20565444
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimanic and long-lasting mood stabilizing effect of memantine in bipolar I mood disorder: two case reports.
    Serra G; De Chiara L; Koukopoulos A; Serra G
    J Clin Psychopharmacol; 2013 Oct; 33(5):715-7. PubMed ID: 24002206
    [No Abstract]   [Full Text] [Related]  

  • 5. The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial.
    Koukopoulos A; Serra G; Koukopoulos AE; Reginaldi D; Serra G
    J Affect Disord; 2012 Jan; 136(1-2):163-166. PubMed ID: 22030128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
    Bowden CL
    J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401
    [No Abstract]   [Full Text] [Related]  

  • 7. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS
    J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood stabilizers for patients with bipolar disorder: the state of the art.
    Altamura AC; Lietti L; Dobrea C; Benatti B; Arici C; Dell'Osso B
    Expert Rev Neurother; 2011 Jan; 11(1):85-99. PubMed ID: 21158558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mood disorders. Bipolar psychosis].
    Gay C; Henry C
    Rev Prat; 2004 Apr; 54(8):877-83; quiz 884. PubMed ID: 15274463
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Hamrin V; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful antimanic treatment and mood stabilization with lamotrigine, clozapine, and valproate in a bipolar patient after lithium-induced cerebellar deterioration. A case report.
    Dembowski C; Rechlin T
    Pharmacopsychiatry; 2003; 36(2):83-6. PubMed ID: 12734768
    [No Abstract]   [Full Text] [Related]  

  • 15. Memantine-related psychotic symptoms in a patient with bipolar disorder.
    Canan F; Ataoglu A
    J Clin Psychiatry; 2010 Jul; 71(7):957. PubMed ID: 20667296
    [No Abstract]   [Full Text] [Related]  

  • 16. Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.
    Lee SY; Wang TY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
    Alcohol Clin Exp Res; 2018 Jun; 42(6):1044-1050. PubMed ID: 29656414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of comorbid bipolar disorder and alcohol dependence].
    Brousse G; Garay RP; Benyamina A
    Presse Med; 2008; 37(7-8):1132-7. PubMed ID: 18296020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a loss of efficacy of lithium in patients treated for over 20 years?
    Berghöfer A; Müller-Oerlinghausen B
    Neuropsychobiology; 2000; 42 Suppl 1():46-9. PubMed ID: 11093072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine prevents "bipolar-like" behavior induced by chronic treatment with imipramine in rats.
    Demontis F; Falconi M; Canu D; Serra G
    Eur J Pharmacol; 2015 Apr; 752():49-54. PubMed ID: 25661848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.